World's Best Scientists 2026 revealed!
Clinical Drug Investigation
H-index 17

Clinical Drug Investigation

1173-2563

Published by: Springer

https://www.springer.com/journal/40261

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1912 70 60 13

Additional Metrics

Number of Best Scientists*: 107
Documents by Best Scientists*: 88
Top 100 Ranked Scientists*: 2
SCIMAGO H-index: 70
SCIMAGO SJR: 0.771
Impact Factor: 2.7

Overview

Top Research Topics at Clinical Drug Investigation?

The journal investigates areas of study like Pharmacotherapy, Internal medicine, Pharmacology, Anesthesia and Adverse effect. Pharmacotherapy research featured in Clinical Drug Investigation incorporates concerns from various other topics such as Surgery, Pharmacology toxicology, Drug and Intensive care medicine. Clinical Drug Investigation focuses on Internal medicine but the discussions also offer insight into other areas such as Gastroenterology, Endocrinology, Oncology and Cardiology.

In the Pharmacology research discussed, Pharmacokinetics and Bioavailability are all tackled. The journal focuses on Pharmacokinetics as well as the interrelated topic of Crossover study. The Crossover study study featured in Clinical Drug Investigation draws parallels with the field of Bioequivalence.

Topics in Anesthesia explored in Clinical Drug Investigation were investigated in conjunction with research in Placebo and Opioid. Tolerability is a key component of Adverse effect research discussed in it. Studies on Tolerability discussed in it link to the field of Blood pressure.

  • Pharmacotherapy (42.33%)
  • Internal medicine (41.14%)
  • Pharmacology (23.22%)

What are the most cited papers published in the journal?

  • Pharmacology of Silymarin (262 citations)
  • Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study. (209 citations)
  • Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study. (187 citations)

Research areas of the most cited articles at Clinical Drug Investigation:

The journal publications explore disciplines such as Pharmacotherapy, Internal medicine, Pharmacology, Anesthesia and Tolerability. The journal articles focus on Pharmacotherapy but the discussions also offer insight into other areas such as Clinical trial, Adverse effect, Immunology, Intensive care medicine and Pharmacology toxicology. While Anesthesia is the key highlight in the most cited articles, thet also covered some subjects on Placebo and Randomized controlled trial, Surgery and Combination therapy.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Surgery
  • Disease

The previous edition focused in particular on these issues:

Internal medicine, Pharmacotherapy, Adverse effect, Pharmacokinetics and Pharmacology toxicology are among the topics commonly tackled in the journal. Gastroenterology, Placebo and Oncology are some topics wherein Internal medicine research discussed in the journal have an impact. While Pharmacotherapy is the focus of the journal, it also provided insights into the studies of Buprenorphine, Disease, Drug and Intensive care medicine.

The work on Adverse effect tackled in the journal brings together disciplines like Diabetes mellitus, Clinical trial, Discontinuation and Combination therapy. Pharmacokinetics research presented in Clinical Drug Investigation encompasses a variety of subjects, including Tolerability and Crossover study. It addresses concerns in Pharmacology which are intertwined with other disciplines, such as Statin and Asthma.

The most cited articles from the last journal are:

  • Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19. (8 citations)
  • Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III trials. (6 citations)
  • Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical Drug Investigation (based on the number of publications) are:

  • Javier Rejas (13 papers) absent at the last edition,
  • Luca Gallelli (12 papers) absent at the last edition,
  • Mona Darwish (12 papers) absent at the last edition,
  • Philmore Robertson (12 papers) absent at the last edition,
  • Yosef S. Haviv (11 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical Drug Investigation (based on the number of publications) are:

  • Pfizer (56 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Novartis (54 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • AstraZeneca (47 papers) published 2 papers at the last edition,
  • Springer Science+Business Media (40 papers) published 6 papers at the last edition, 3 more than at the previous edition,
  • University of Milan (38 papers) published 1 paper at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 8.41% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 18.37% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.14% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 9.18% of all publications and 65.31% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Understanding the Impact of Research at Clinical Drug Investigation on Online Nursing Education

A closer examination of the impact of research published in Clinical Drug Investigation on the field of online nursing education could offer layers of depth according to the Google Search Quality Guidelines. While the articles in this journal primarily focus on Pharmacotherapy, Internal medicine, and Pharmacology, the concepts studied directly influence the curriculum of nursing programs, especially those offered online. The cutting-edge research presented in the Clinical Drug Investigation equips the future generation of nursing professionals with the latest practices in pharmacotherapy and internal medicine. It further empowers them to anticipate and effectively handle adverse effects of medication, a critical aspect of nursing. For instance, understanding the Pharmacology of Silymarin, one of the most cited papers in the journal, could be extremely beneficial for nursing students dealing with patients who use this herbal supplement. Moreover, the journal’s focus on Anesthesia and related studies on Placebo and Opioid use directly correlates with the nursing practice, where pain management is paramount. Meanwhile, in the era of digital learning, online nursing schools in best online nursing programs in Wyoming and elsewhere are increasingly integrating such topical research into their curriculum. By doing so, they ensure that the future tide of healthcare professionals is abreast with the latest developments in the field. As such, the myriad of research exploring Pharmacotherapy, Internal medicine, Pharmacology, and related areas published in the Clinical Drug Investigation is potentially influencing the field of nursing education, shaping the nurse leaders of the future.

Top Publications

  • Cannabidiol in the Treatment of Epilepsy.

    Randi von Wrede;Christoph Helmstaedter;Rainer Surges

    (2021)
    85 Citations
  • Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study

    (2021)
    52 Citations
  • Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS)

    Xenofon Baraliakos;Mikkel Østergaard;Mikkel Østergaard;Lianne S Gensler;Denis Poddubnyy

    (2020)
    42 Citations
  • PCSK9 Inhibitors' New Users: Analysis of Prescription Patterns and Patients' Characteristics from an Italian Real-world Study.

    Carlo Piccinni;Ippazio Cosimo Antonazzo;Aldo P Maggioni;Antonella Pedrini

    (2020)
    27 Citations
  • The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial

    (2022)
    23 Citations
  • Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation.

    Michela Giustozzi;Matteo Mazzetti;Maurizio Paciaroni;Giancarlo Agnelli

    (2021)
    22 Citations
  • Multiple Sclerosis Relapses Following Cessation of Fingolimod

    (2022)
    19 Citations
  • Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients.

    Vincenzo Di Nunno;Matteo Santoni;Veronica Mollica;Alessandro Conti

    (2020)
    17 Citations
  • Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

    Katja Weisel;Thomas Martin;Amrita Krishnan;Sundar Jagannath

    (2021)
    17 Citations
  • Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density

    Paul D Miller;Steven Troy;Richard J Weiss;Miriam Annett

    (2021)
    16 Citations

Related Online Degrees & Career Pathways

For those interested in the medical field but seeking alternatives or stepping stones to becoming a doctor, there are several valuable online degree options. Medical assistant programs offer a practical entry point, providing training that can be completed remotely with the potential for financial aid. These programs equip students with essential clinical and administrative skills to work alongside healthcare professionals.

For certified medical assistants looking to advance, the CMA to LPN bridge program online can be an efficient pathway. It allows professionals to build on their experience and credentials, often with flexible scheduling to accommodate current work commitments.

Those drawn to the science behind medicine might consider online biology degrees, which provide a solid foundation in biological sciences and can open doors to various healthcare and research careers. These programs often lead to graduate studies or specialized certifications.

The nursing field also offers robust online options, such as ASN online programs, which prepare students for licensure as registered nurses. This pathway is critical given the ongoing demand for skilled nurses, and online ASN programs balance convenience with comprehensive clinical training requirements.

Best Scientists Contributing to This Journal

Recently Published Articles